SLC22, SLC44, and SLC47 Transporters-Organic Anion and Cation Transporters: Molecular and Cellular Properties

Current Topics in Membranes

Volumn 73, Issue , 2014, Pages 233-261

  Pelis, Ryan M ^a   Wright, Stephen H ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Counter transport; Exchange; Kidney; Liver; MATE; OAT; OCT; Organic anion; Organic cation; Proximal tubule; Transport

Indexed keywords

ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER;

ANIMAL; CELLS; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; CELLS; HUMANS; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS;

EID: 84898648573     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800223-0.00006-2     Document Type: Chapter

References (142)

1. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009, 323:1718-1722.
2. Anzai N., Jutabha P., Enomoto A., Yokoyama H., Nonoguchi H., Hirata T., et al. Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. The Journal of Pharmacology and Experimental Therapeutics 2005, 315:534-544.
3. Anzai N., Miyazaki H., Noshiro R., Khamdang S., Chairoungdua A., Shin H.J., et al. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. The Journal of Biological Chemistry 2004, 279:45942-45950.
4. Asif A.R., Steffgen J., Metten M., Grunewald R.W., Muller G.A., Bahn A., et al. Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells. Pflügers Archiv 2005, 450:88-95.
5. Aslamkhan A., Han Y.H., Walden R., Sweet D.H., Pritchard J.B. Stoichiometry of organic anion/dicarboxylate exchange in membrane vesicles from rat renal cortex and hOAT1-expressing cells. American Journal of Physiology. Renal Physiology 2003, 285:F775-F783.
6. Astorga B., Ekins S., Morales M., Wright S.H. Molecular determinants of ligand selectivity for the human multidrug and toxin extrusion proteins, MATE1 and MATE-2K. Journal of Pharmacology and Experimental Therapeutics 2012, 341:743-755.
7. Astorga B., Wunz T.M., Morales M., Wright S.H., Pelis R.M. Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3). American Journal of Physiology. Renal Physiology 2011, 301:F378-F386.
8. Bacher P., Giersiefer S., Bach M., Fork C., Schomig E., Grundemann D. Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: Gain-of-function by interchange of selected amino acids. Biochimica et Biophysica Acta 2009, 1788:2594-2602.
9. Bahn A., Hagos Y., Reuter S., Balen D., Brzica H., Krick W., et al. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). Journal of Biological Chemistry 2008, 283:16332-16341.
10. Barendt W.M., Wright S.H. The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization. Journal of Biological Chemistry 2002, 277:22491-22496.
11. Barros S.A., Srimaroeng C., Perry J.L., Walden R., Dembla-Rajpal N., Sweet D.H., et al. Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport. Journal of Biological Chemistry 2009, 284:2672-2679.
12. Bleasby K., Castle J.C., Roberts C.J., Cheng C., Bailey W.J., Sina J.F., et al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition. Xenobiotica 2006, 36:963-988.
13. Brast S., Grabner A., Sucic S., Sitte H.H., Hermann E., Pavenstadt H., et al. The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization. FASEB Journal 2011, 26:976-986.
14. Brzica H., Breljak D., Ljubojevic M., Balen D., Micek V., Anzai N., et al. Optimal methods of antigen retrieval for organic anion transporters in cryosections of the rat kidney. Arhiv za Higijenu Rada i Toksikologiju 2009, 60:7-17.
15. Budiman T., Bamberg E., Koepsell H., Nagel G. Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat. Journal of Biological Chemistry 2000, 275:29413-29420.
16. Burckhardt G., Wolff N.A. Structure of renal organic anion and cation transporters. American Journal of Physiology. Renal Physiology 2000, 278:F853-F866.
17. Burckhardt B.C., Wolff N.A., Burckhardt G. Electrophysiologic characterization of an organic anion transporter cloned from winter flounder kidney (fROAT). Journal of the American Society of Nephrology 2000, 11:9-17.
18. Busch A.E., Quester S., Ulzheimer J.C., Waldegger S., Gorboulev V., Arndt P., et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. Journal of Biological Chemistry 1996, 271:32599-32604.
19. Cha S.H., Sekine T., Fukushima J.I., Kanai Y., Kobayashi Y., Goya T., et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Molecular Pharmacology 2001, 59:1277-1286.
20. Cha S.H., Sekine T., Kusuhara H., Yu E., Kim J.Y., Kim D.K., et al. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. Journal of Biological Chemistry 2000, 275:4507-4512.
21. Chen Y., Zhang S., Sorani M., Giacomini K.M. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. The Journal of Pharmacology and Experimental Therapeutics 2007, 322:695-700.
22. Cheng X., Klaassen C.D. Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metabolism and Disposition 2009, 37:2178-2185.
23. Dangprapai Y., Wright S.H. Interaction of H+ with the extracellular and intracellular aspects of hMATE1. American Journal of Physiology. Renal Physiology 2011, 301:F520-F528.
24. Duan P., Li S., Ai N., Hu L., Welsh W.J., You G. Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: Discovery and molecular characterization. Molecular Pharmacology 2012, 9:3340-3346.
25. Duan P., Li S., You G. Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: Accelerating endocytosis of the transporter. European Journal of Pharmacology 2010, 627:49-55.
26. Duan P., Li S., You G. Transmembrane peptide as potent inhibitor of oligomerization and function of human organic anion transporter 1. Molecular Pharmacology 2011, 79:569-574.
27. Duan P., Li S., You G. Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A. International Journal of Biochemistry and Molecular Biology 2012, 3:322-327.
28. Ekaratanawong S., Anzai N., Jutabha P., Miyazaki H., Noshiro R., Takeda M., et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. Journal of Pharmacological Sciences 2004, 94:297-304.
29. Ekins S., Kim R.B., Leake B.F., Dantzig A.H., Schuetz E.G., Lan L.B., et al. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. Molecular Pharmacology 2002, 61:974-981.
30. Endres C.J., Hsiao P., Chung F.S., Unadkat J.D. The role of transporters in drug interactions. European Journal of Pharmaceutical Sciences 2006, 27:501-517.
31. Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S.H., et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417:447-452.
32. Enomoto A., Takeda M., Shimoda M., Narikawa S., Kobayashi Y., Kobayashi Y., et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. Journal of Pharmacology and Experimental Therapeutics 2002, 301:797-802.
33. Enomoto A., Wempe M.F., Tsuchida H., Shin H.J., Cha S.H., Anzai N., et al. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. The Journal of Biological Chemistry 2002, 277:36262-36271.
34. Eraly S.A., Hamilton B.A., Nigam S.K. Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochemical and Biophysical Research Communications 2003, 300:333-342.
35. Eraly S.A., Monte J.C., Nigam S.K. Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiological Genomics 2004, 18:12-24.
36. Forrest L.R., Kramer R., Ziegler C. The structural basis of secondary active transport mechanisms. Biochimica et Biophysica Acta 2011, 1807:167-188.
37. Garrigues A., Loiseau N., Delaforge M., Ferte J., Garrigos M., Andre F., et al. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. Molecular Pharmacology 2002, 62:1288-1298.
38. Gisler S.M., Pribanic S., Bacic D., Forrer P., Gantenbein A., Sabourin L.A., et al. PDZK1: I. A major scaffolder in brush borders of proximal tubular cells. Kidney International 2003, 64:1733-1745.
39. Gong S., Lu X., Xu Y., Swiderski C.F., Jordan C.T., Moscow J.A. Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias. Experimental Hematology 2002, 30:1162-1169.
40. Gorboulev V., Shatskaya N., Volk C., Koepsell H. Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region. Molecular Pharmacology 2005, 67:1612-1619.
41. Gorboulev V., Volk C., Arndt P., Akhoundova A., Koepsell H. Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate. Molecular Pharmacology 1999, 56:1254-1261.
42. Gründemann D., Gorboulev V., Gambaryan S., Veyhl M., Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994, 372:549-552.
43. Gründemann D., Harlfinger S., Golz S., Geerts A., Lazar A., Berkels R., et al. Discovery of the ergothioneine transporter. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:5256-5261.
44. Hagos Y., Stein D., Ugele B., Burckhardt G., Bahn A. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. Journal of the American Society of Nephrology 2007, 18:430-439.
45. Han T.K., Everett R.S., Proctor W.R., Ng C.M., Costales C.L., Brouwer K.L., et al. Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes. Molecular Pharmacology 2013, 84:182-189.
46. Harper J.N., Wright S.H. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2. American Journal of Physiology. Renal Physiology 2012, 304:F56-F67.
47. Hasannejad H., Takeda M., Taki K., Jung S.H., Babu E., Jutabha P., et al. Interactions of human organic anion transporters with diuretics. The Journal of Pharmacology and Experimental Therapeutics 2004, 308:1021-1029.
48. He X., Szewczyk P., Karyakin A., Evin M., Chang G. Structure of a cation-bound multidrug and toxin compound extrusion (MATE) transporter. Nature 2010, 467:991-994.
49. Hong M., Xu W., Yoshida T., Tanaka K., Wolff D.J., Zhou F., et al. Human organic anion transporter hOAT1 forms homooligomers. Journal of Biological Chemistry 2005, 280:32285-32290.
50. Hosoyamada M., Ichida K., Enomoto A., Hosoya T., Endou H. Function and localization of urate transporter 1 in mouse kidney. Journal of the American Society of Nephrology 2004, 15:261-268.
51. Hosoyamada M., Sekine T., Kanai Y., Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. American Journal of Physiology 1999, 276:F122-F128.
52. Hosoyamada M., Takiue Y., Shibasaki T., Saito H. The effect of testosterone upon the urate reabsorptive transport system in mouse kidney. Nucleosides, Nucleotides & Nucleic Acids 2010, 29:574-579.
53. Kaler G., Truong D.M., Khandelwal A., Nagle M., Eraly S.A., Swaan P.W., et al. Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. The Journal of Biological Chemistry 2007, 282:23841-23853.
54. Kekuda R., Prasad P.D., Wu X., Wang H., Fei Y.J., Leibach F.H., et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. Journal of Biological Chemistry 1998, 273:15971-15979.
55. Keller T., Egenberger B., Gorboulev V., Bernhard F., Uzelac Z., Gorbunov D., et al. The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization. Journal of Biological Chemistry 2011, 286:37874-37886.
56. Kikuchi R., Kusuhara H., Hattori N., Kim I., Shiota K., Gonzalez F.J., et al. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. Molecular Pharmacology 2007, 72:1619-1625.
57. +/organic cation antiporter with a long hydrophobic tail. Archives of Biochemistry and Biophysics 2008, 469:195-199.
58. Kobayashi Y., Ohshiro N., Sakai R., Ohbayashi M., Kohyama N., Yamamoto T. Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). The Journal of Pharmacy and Pharmacology 2005, 57:573-578.
59. Koepsell H., Endou H. The SLC22 drug transporter family. Pflügers Archiv 2004, 447:666-676.
60. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharmaceutical Research 2007, 24:1227-1251.
61. Komatsu T., Hiasa M., Miyaji T., Kanamoto T., Matsumoto T., Otsuka M., et al. Characterization of the human MATE2 proton-coupled polyspecific organic cation exporter. The International Journal of Biochemistry & Cell Biology 2011, 43:913-918.
62. Kusuhara H., Sekine T., Utsunomiya-Tate N., Tsuda M., Kojima R., Cha S.H., et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. The Journal of Biological Chemistry 1999, 274:13675-13680.
63. Li S., Duan P., You G. Regulation of human organic anion transporter 1 by ANG II: Involvement of protein kinase Calpha. American Journal of Physiology. Endocrinology and Metabolism 2009, 296:E378-E383.
64. Li S., Duan P., You G. Regulation of human organic anion transporter 3 by peptide hormone bradykinin. Journal of Pharmacology and Experimental Therapeutics 2010, 333:970-975.
65. Li Q., Peng X., Yang H., Wang H., Shu Y. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice. Molecular Pharmaceutics 2011, 8:2476-2483.
66. Li S., Zhang Q., You G. Three ubiquitination sites of organic anion transporter-1 synergistically mediate protein kinase C-dependent endocytosis of the transporter. Molecular Pharmacology 2013, 84:139-146.
67. Lopez-Nieto C.E., You G., Bush K.T., Barros E.J., Beier D.R., Nigam S.K. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. Journal of Biological Chemistry 1997, 272:6471-6478.
68. Lu Y., Nakanishi T., Tamai I. Functional cooperation of SMCTs and URAT1 for renal reabsorption transport of urate. Drug Metabolism and Pharmacokinetics 2013, 28:153-158.
69. +/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. Journal of the American Society of Nephrology 2006, 17:2127-2135.
70. Michel V., Yuan Z., Ramsubir S., Bakovic M. Choline transport for phospholipid synthesis. Experimental Biology and Medicine (Maywood, N.J.) 2006, 231:490-504.
71. Minuesa G., Volk C., Molina-Arcas M., Gorboulev V., Erkizia I., Arndt P., et al. Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. Journal of Pharmacology and Experimental Therapeutics 2009, 329:252-261.
72. Miura D., Anzai N., Jutabha P., Chanluang S., He X., Fukutomi T., et al. Human urate transporter 1 (hURAT1) mediates the transport of orotate. The Journal of Physiological Sciences 2011, 61:253-257.
73. Miyazaki H., Anzai N., Ekaratanawong S., Sakata T., Shin H.J., Jutabha P., et al. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. Journal of the American Society of Nephrology 2005, 16:3498-3506.
74. Motohashi H., Nakao Y., Masuda S., Katsura T., Kamba T., Ogawa O., et al. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney. Journal of Pharmaceutical Sciences 2013, 102:3302-3308.
75. Motohashi H., Sakurai Y., Saito H., Masuda S., Urakami Y., Goto M., et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. Journal of the American Society of Nephrology 2002, 13:866-874.
76. Nies A.T., Koepsell H., Damme K., Schwab M. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handbook of Experimental Pharmacology 2011, 201:105-167.
77. Ohashi R., Tamai I., Nezu J.J., Nikaido H., Hashimoto N., Oku A., et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Molecular Pharmacology 2001, 59:358-366.
78. + antiporter in the kidney. Drug Metabolism and Disposition 2006, 34:1868-1874.
79. Okuda M., Saito H., Urakami Y., Takano M., Inui K.-I. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochemical and Biophysical Research Communications 1996, 224:500-507.
80. O'Regan S., Traiffort E., Ruat M., Cha N., Compaore D., Meunier F.M. An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1835-1840.
81. Otsuka M., Matsumoto T., Morimoto R., Arioka S., Omote H., Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17923-17928.
82. Pelis R.M., Wright S.H. Renal transport of organic anions and cations. Comprehensive Physiology 2011, 1:1795-1835.
83. Perry J.L., Dembla-Rajpal N., Hall L.A., Pritchard J.B. A three-dimensional model of human organic anion transporter 1: Aromatic amino acids required for substrate transport. The Journal of Biological Chemistry 2006, 281:38071-38079.
84. Popp C., Gorboulev V., Muller T.D., Gorbunov D., Shatskaya N., Koepsell H. Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Molecular Pharmacology 2005, 67:1600-1611.
85. Pornillos O., Chang G. Inverted repeat domains in membrane proteins. FEBS Letters 2006, 580:358-362.
86. Pritchard J.B. Coupled transport of p-aminohippurate by rat kidney basolateral membrane vesicles. American Journal of Physiology 1988, 255:F597-F604.
87. Pritchard J.B. Intracellular α-ketoglutarate controls the efficacy of renal organic anion transport. The Journal of Pharmacology and Experimental Therapeutics 1995, 274:1278-1284.
88. Radestock S., Forrest L.R. The alternating-access mechanism of MFS transporters arises from inverted-topology repeats. Journal of Molecular Biology 2011, 407:698-715.
89. Reddy V.S., Shlykov M.A., Castillo R., Sun E.I., Saier M.H. The major facilitator superfamily (MFS) revisited. The FEBS Journal 2012, 279:2022-2035.
90. Rizwan A.N., Krick W., Burckhardt G. The chloride dependence of the human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid. Journal of Biological Chemistry 2007, 282:13402-13409.
91. Rocchiccioli F., Leroux J.P., Cartier P.H. Microdetermination of 2-ketoglutaric acid in plasma and cerebrospinal fluid by capillary gas chromatography mass spectroscopy: Application in pediatrics. Biomedical Mass Spectrometry 1984, 24:28.
92. Roth M., Timmermann B.N., Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metabolism and Disposition 2011, 39:920-926.
93. Sato M., Wakayama T., Mamada H., Shirasaka Y., Nakanishi T., Tamai I. Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats. Biochimica et Biophysica Acta 2011, 1808:1441-1447.
94. Schaeffeler E., Hellerbrand C., Nies A.T., Winter S., Kruck S., Hofmann U., et al. DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma. Genome Medicine 2011, 3:82.
95. Schmitt B.M., Koepsell H. Alkali cation binding and permeation in the rat organic cation transporter rOCT2. The Journal of Biological Chemistry 2005, 280:24481-24490.
96. Schomig E., Spitzenberger F., Engelhardt M., Martel F., Ording N., Gründemann D. Molecular cloning and characterization of two novel transport proteins from rat kidney. FEBS Letters 1998, 425:79-86.
97. Schumacher M.A., Brennan R.G. Deciphering the molecular basis of multidrug recognition: Crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR. Research in Microbiology 2003, 154:69-77.
98. Sekine T., Watanabe N., Hosoyamada M., Kanaim Y., Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. The Journal of Biological Chemistry 1997, 272:18526-18529.
99. + of p-aminohippuric acid uptake into rat renal basolateral membrane vesicles. American Journal of Physiology 1987, 253:F795-F801.
100. Shin H.J., Anzai N., Enomoto A., He X., Kim D.K., Endou H., et al. Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 2007, 45:1046-1055.
101. Simonson G.D., Vincent A.C., Roberg K.J., Huang Y., Iwanij V. Molecular cloning and characterization of a novel liver-specific transport protein. Journal of Cell Science 1994, 107:3-72.
102. Sissung T.M., Troutman S.M., Campbell T.J., Pressler H.M., Sung H., Bates S.E., et al. Transporter pharmacogenetics: Transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy. Discovery Medicine 2012, 13:19-34.
103. Srimaroeng C., Perry J.L., Pritchard J.B. Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica 2008, 38:889-935.
104. Sun W., Wu R.R., van Poelje P.D., Erion M.D. Isolation of a family of organic anion transporters from human liver and kidney. Biochemical and Biophysical Research Communications 2001, 283:417-422.
105. + gradient. American Journal of Physiology. Renal Physiology 2003, 284:F763-F769.
106. Takeda M., Sekine T., Endou H. Regulation by protein kinase C of organic anion transport driven by rat organic anion transporter 3 (rOAT3). Life Sciences 2000, 67:1087-1093.
107. +-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochimica et Biophysica Acta 2001, 1512:273-284.
108. Tamai I., Nakanishi T., Kobayashi D., China K., Kosugi Y., Nezu J., et al. Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Molecular Pharmacology 2004, 1:57-66.
109. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. Journal of Biological Chemistry 1998, 273:20378-20382.
110. Tamai I., Yabuuchi H., Nezu J.-I., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Letters 1997, 419:107-111.
111. Tanaka K., Xu W., Zhou F., You G. Role of glycosylation in the organic anion transporter OAT1. The Journal of Biological Chemistry 2004, 279:14961-14966.
112. Tanaka K., Zhou F., Kuze K., You G. Cysteine residues in the organic anion transporter mOAT1. Biochemical Journal 2004, 380:283-287.
113. Tasic V., Hynes A.M., Kitamura K., Cheong H.I., Lozanovski V.J., Gucev Z., et al. Clinical and functional characterization of URAT1 variants. PLoS One 2011, 6:e28641.
114. Traiffort E., O'Regan S., Ruat M. The choline transporter-like family SLC44: Properties and roles in human diseases. Molecular Aspects of Medicine 2013, 34:646-654.
115. Tsigelny I.F., Kovalskyy D., Kouznetsova V.L., Balinskyi O., Sharikov Y., Bhatnagar V., et al. Conformational changes of the multispecific transporter organic anion transporter 1 (OAT1/SLC22A6) suggests a molecular mechanism for initial stages of drug and metabolite transport. Cell Biochemistry and Biophysics 2011, 61:251-259.
116. +/organic cation antiporter MATE1. American Journal of Physiology. Renal Physiology 2007, 292:F593-F598.
117. Tsuda M., Terada T., Mizuno T., Katsura T., Shimakura J., Inui K.I. Targeted disruption of the multidrug and toxin extrusion 1 (Mate1) gene in mice reduces renal secretion of metformin. Molecular Pharmacology 2009, 75:1280-1286.
118. Tsuda M., Terada T., Ueba M., Sato T., Masuda S., Katsura T., et al. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells. Journal of Pharmacology and Experimental Therapeutics 2009, 329:185-191.
119. Tzvetkov M.V., Vormfelde S.V., Balen D., Meineke I., Schmidt T., Sehrt D., et al. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clinical Pharmacology and Therapeutics 2009, 86:299-306.
120. U.S.Food and Drug Administration Guidance for Industry: Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations 2012, Huang, S.-M. and Zhang, L. Draft Guidance, 79 pp.
121. U.S.Food and Drug Administration Preventable Adverse Drug Reactions: A Focus on Drug Interactions 2012, U.S. FDA.
122. Uwai Y., Ida H., Tsuji Y., Katsura T., Inui K. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharmaceutical Research 2007, 24:811-815.
123. Vanwert A.L., Gionfriddo M.R., Sweet D.H. Organic anion transporters: Discovery, pharmacology, regulation and roles in pathophysiology. Biopharmaceutics & Drug Disposition 2010, 31:1-71.
124. Westholm D.E., Salo D.R., Viken K.J., Rumbley J.N., Anderson G.W. The blood-brain barrier thyroxine transporter organic anion-transporting polypeptide 1c1 displays atypical transport kinetics. Endocrinology 2009, 150:5153-5162.
125. Winter T.N., Elmquist W.F., Fairbanks C.A. OCT2 and MATE1 provide bidirectional agmatine transport. Molecular Pharmaceutics 2011, 8:133-142.
126. Wittwer M.B., Zur A.A., Khuri N., Kido Y., Kosaka A., Zhang X., et al. Discovery of potent, selective MATE1 inhibitors through prescription drug profiling and computational modeling. Journal of Medicinal Chemistry 2013, 56:781-795.
127. Wolff N.A., Thies K., Kuhnke N., Reid G., Friedrich B., Lang F., et al. Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization. Journal of the American Society of Nephrology 2003, 14:1959-1968.
128. Wright S.H., Wunz T.M. Transport of tetraethylammonium by rabbit renal brush-border and basolateral membrane vesicles. American Journal of Physiology 1987, 253:F1040-F1050.
129. + exchanger of rabbit renal brush-border membrane vesicles. Journal of Biological Chemistry 1988, 263:19494-19497.
130. + exchange in isolated renal brush-border membrane vesicles. Biochimica et Biophysica Acta 1995, 1240:18-24.
131. Wu X., Huang W., Ganapathy M.E., Wang H., Kekuda R., Conway S.J., et al. Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. American Journal of Physiology. Renal Physiology 2000, 279:F449-F458.
132. Yang C.H., Glover K.P., Han X. Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. Toxicological Sciences 2010, 117:294-302.
133. You G., Kuze K., Kohanski R.A., Amsler K., Henderson S. Regulation of mOAT-mediated organic anion transport by okadaic acid and protein kinase C in LLC-PK(1) cells. Journal of Biological Chemistry 2000, 275:10278-10284.
134. Youngblood G.L., Sweet D.H. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. American Journal of Physiology. Renal Physiology 2004, 287:F236-F244.
135. Yuan Z., Tie A., Tarnopolsky M., Bakovic M. Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1. Physiological Genomics 2006, 26:76-90.
136. Zhang X., He X., Baker J., Tama F., Chang G., Wright S.H. Twelve transmembrane helices form the functional core of mammalian MATE1 (multidrug and toxin extruder 1) protein. The Journal of Biological Chemistry 2012, 287:27971-27982.
137. Zhang Q., Hong M., Duan P., Pan Z., Ma J., You G. Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway. The Journal of Biological Chemistry 2008, 283:32570-32579.
138. Zhang X., Shirahatti N.V., Mahadevan D., Wright S.H. A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2). The Journal of Biological Chemistry 2005, 280:34813-34822.
139. Zhang Q., Suh W., Pan Z., You G. Short-term and long-term effects of protein kinase C on the trafficking and stability of human organic anion transporter 3. International Journal of Biochemistry and Molecular Biology 2012, 3:242-249.
140. Zhang X., Wright S.H. MATE1 has an external COOH terminus, consistent with a 13-helix topology. American Journal of Physiology. Renal Physiology 2009, 297:F263-F271.
141. Zhou F., Hong M., You G. Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells. American Journal of Physiology. Endocrinology and Metabolism 2007, 293:E57-E61.
142. Zhou F., Xu W., Hong M., Pan Z., Sinko P.J., Ma J., et al. The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Molecular Pharmacology 2005, 67:868-876.